Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s97. https://doi.org/10.25251/skin.1.supp.96